J&J’s research shows adults with Type 2 Diabetes get greater blood glucose control with Invokana (canagliflozin)
J&J has annonced that results of a new analysis of data from real-world clinical practice show that, in adults with type 2 diabetes
Pharmaceuticals, Biotechnology and Life Sciences
J&J has annonced that results of a new analysis of data from real-world clinical practice show that, in adults with type 2 diabetes
Scientists have long been interested in how the vascular system — the body’s network of large and small blood vessels — may be involved in the onset and progression of Alzheimer’s disease and related dementias.
Ethicon, a medical device company of the Johnson & Johnson family of companies, has announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.
Making the most of the low light in the muddy rivers where it swims, the elephant nose fish survives…
Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP, 1 gram/4mL (250 mg/mL) vials…
GW Pharmaceutical announces positive Phase 3 test results for Epidiolex (Dravet syndrome)
United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance to Horizon Pharma for U.S. patent application number…
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab…
Sanofi welcomes new Executive Committee member
Sanofi and MSD/Merck in joint vaccines operations in Europe